Ani Pharmaceuticals (ANIP) Treasury Shares (2013 - 2026)

Ani Pharmaceuticals has disclosed Treasury Shares across 13 years of filings, most recently posting $53.0 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $53.0 million, up 70.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.0 million (up 70.74% YoY), and the FY2025 annual result was $33.2 million, up 58.03% from the prior year.
• Treasury Shares came in at $53.0 million for Q1 2026 at Ani Pharmaceuticals, up from $33.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.4 million in Q1 2023 to a low of $123000.0 in Q1 2022.
• The 5-year median for Treasury Shares is $430000.0 (2024), against an average of $564926.9.
• Peak annual rise in Treasury Shares reached 256.82% in 2025, while the deepest fall reached 58.03% in 2025.
• Ani Pharmaceuticals' Treasury Shares stood at $5.1 million in 2022, then surged by 97.9% to $10.1 million in 2023, then soared by 108.71% to $21.0 million in 2024, then jumped by 58.03% to $33.2 million in 2025, then surged by 59.42% to $53.0 million in 2026.
• The last three Treasury Shares figures came in at $53.0 million (Q1 2026), $33.2 million (Q4 2025), and $32.6 million (Q3 2025), per Business Quant data.